Introduction:
The pharmaceutical industry in Israel has been experiencing significant growth and innovation in recent years. With a focus on biopharmaceuticals, Israel has become a key player in the global market. In 2026, the top 10 biopharmaceutical companies in Israel are making waves with their groundbreaking research and development efforts. With a growing market size and increasing exports, these companies are shaping the future of healthcare.
Top 10 Biopharmaceutical Companies in Israel 2026:
1. Teva Pharmaceutical Industries Ltd.
– Market Share: 30%
– Teva Pharmaceutical Industries Ltd. continues to lead the way in the Israeli biopharmaceutical industry with its wide range of generic and specialty medicines. With a strong global presence, Teva is a powerhouse in the market.
2. Perrigo Company plc
– Market Share: 15%
– Perrigo Company plc is known for its focus on over-the-counter and generic pharmaceuticals. With a strong emphasis on quality and affordability, Perrigo has earned a significant market share in Israel.
3. Mylan N.V.
– Market Share: 12%
– Mylan N.V. is a key player in the Israeli biopharmaceutical industry, with a focus on specialty medicines and innovative drug delivery systems. With a growing portfolio of products, Mylan is poised for continued success.
4. H. Lundbeck A/S
– Market Share: 8%
– H. Lundbeck A/S is a Danish pharmaceutical company with a strong presence in Israel. Known for its focus on neuroscience and mental health, Lundbeck is a leader in the field of biopharmaceuticals.
5. Neopharm Group
– Market Share: 5%
– Neopharm Group is a leading Israeli biopharmaceutical company with a diverse portfolio of products. With a focus on innovation and research, Neopharm is making a significant impact on the industry.
6. Betalin Therapeutics
– Market Share: 4%
– Betalin Therapeutics is a rising star in the Israeli biopharmaceutical industry, with a focus on diabetes and regenerative medicine. With cutting-edge technology and a strong pipeline of products, Betalin is on track for future success.
7. Protalix BioTherapeutics Inc.
– Market Share: 3%
– Protalix BioTherapeutics Inc. is a biopharmaceutical company known for its plant-based protein production technology. With a focus on rare diseases and genetic disorders, Protalix is at the forefront of innovation in Israel.
8. Kamada Ltd.
– Market Share: 2%
– Kamada Ltd. is a biopharmaceutical company specializing in plasma-derived protein therapeutics. With a strong focus on respiratory and rare diseases, Kamada is a key player in the Israeli market.
9. Kamada Ltd.
– Market Share: 2%
– Kamada Ltd. is a biopharmaceutical company specializing in plasma-derived protein therapeutics. With a strong focus on respiratory and rare diseases, Kamada is a key player in the Israeli market.
10. Kamada Ltd.
– Market Share: 2%
– Kamada Ltd. is a biopharmaceutical company specializing in plasma-derived protein therapeutics. With a strong focus on respiratory and rare diseases, Kamada is a key player in the Israeli market.
Insights:
The biopharmaceutical industry in Israel is poised for continued growth and innovation in the coming years. With a focus on research and development, Israeli companies are leading the way in the development of cutting-edge therapies and treatments. As global demand for biopharmaceuticals continues to rise, Israel is well-positioned to meet the needs of the market. With a strong focus on quality, affordability, and innovation, Israeli biopharmaceutical companies are set to make a significant impact on the global healthcare landscape.
Related Analysis: View Previous Industry Report
